EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 1 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,989 | -99.9% | 593,018 | -0.6% | 0.00% | 0.0% |
| Q3 2022 | $5,912,000 | +1.2% | 596,572 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $5,840,000 | +0.1% | 596,572 | -0.4% | 0.00% | +33.3% |
| Q1 2022 | $5,835,000 | +394.1% | 599,127 | +345.6% | 0.00% | +200.0% |
| Q4 2021 | $1,181,000 | -6.7% | 134,468 | -6.3% | 0.00% | 0.0% |
| Q3 2021 | $1,266,000 | -13.6% | 143,481 | -12.2% | 0.00% | 0.0% |
| Q2 2021 | $1,465,000 | – | 163,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |